iSpecimen, Inc. (ISPC)
|Net Income (ttm)||-4.65M|
iSpecimen, Inc. has filed to go public with an IPO on the NASDAQ.
Lexington, Massachusetts-based iSpecimen was founded to create a marketplace connecting biopharmaceutical and academic researchers with a large selection of human biospecimens and related information.
iSpecimen is technology-driven company founded to address a critical challenge: how to connect life science researchers who need human biofluids, tissues, and living cells (“biospecimens”) for their research, with the billions of biospecimens available (but not easily accessible) in healthcare provider organizations worldwide. Our ground-breaking iSpecimen Marketplace platform was designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. The iSpecimen Marketplace brings new capabilitie... [Read more...]
Biological Resource Service
|IPO Date |
|Stock Exchange |
|Ticker Symbol |
In 2020, iSpecimen's revenue was $8.18 million, an increase of 90.40% compared to the previous year's $4.30 million. Losses were -$4.65 million, -1.59% less than in 2019.